Neurotrophic keratopathy: Clinical presentation and effects of cenegermin
Purpose: To report on 4 patients (3 adults, 1 child) with neurotrophic keratopathy (NK) treated with cenegermin 20 μg/ml (Oxervate®), a recombinant human nerve growth factor (rhNGF), which was authorized by the European Medicines Agency for the treatment of neurotrophic keratopathy stage 2 and stage...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Elsevier
2022-06-01
|
| 叢編: | American Journal of Ophthalmology Case Reports |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2451993622002341 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|